This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Watson R., Preedy V.: Omega Fatty Acids in Brain and Neurological Health. 2nd Edition. Academic Press, Cambridge MA, 2019.WatsonR.PreedyV.Omega Fatty Acids in Brain and Neurological Health. 2nd EditionAcademic PressCambridge MA2019Search in Google Scholar
Zivkovic A.M., Telis N., German J.B., Hammock B.D.: Dietary omega-3 fatty acids aid in the modulation of inflammation and metabolic health. Calif. Agric., 2011; 65: 106–111.ZivkovicA.M.TelisN.GermanJ.B.HammockB.D.Dietary omega-3 fatty acids aid in the modulation of inflammation and metabolic healthCalif. Agric20116510611110.3733/ca.v065n03p106Search in Google Scholar
Hanna V.S., Hafez E.A.: Synopsis of arachidonic acid metabolism: A review. J. Adv. Res., 2018; 11: 23–32.HannaV.S.HafezE.A.Synopsis of arachidonic acid metabolism: A reviewJ. Adv. Res201811233210.1016/j.jare.2018.03.005Search in Google Scholar
Lowin T., Straub R.H.: Cannabinoid-based drugs targeting CB1 and TRPV1, the sympathetic nervous system, and arthritis. Arthritis Res. Ther., 2015; 17: 226.LowinT.StraubR.H.Cannabinoid-based drugs targeting CB1 and TRPV1, the sympathetic nervous system, and arthritisArthritis Res. Ther20151722610.1186/s13075-015-0743-xSearch in Google Scholar
Burdan F., Chałas A., Szumiło J.: Cyclooxygenase and prostanoids: biological implications. Postępy Hig. Med. Dośw., 2006; 60: 129–141.BurdanF.ChałasA.SzumiłoJ.Cyclooxygenase and prostanoids: biological implicationsPostępy Hig. Med. Dośw200660129141Search in Google Scholar
Fonteh A.N., Wykle R.L.: Arachidonate Remodeling and Inflammation. Birkhäuser Basel, Basel 2004.FontehA.N.WykleR.L.Arachidonate Remodeling and InflammationBirkhäuser Basel, Basel200410.1007/978-3-0348-7848-7Search in Google Scholar
Kudalkar S.N., Rouzera C.A., Marnett L.J.: The peroxidase and cyclooxygenase activity of prostaglandin H synthase. In: Heme Peroxdases, Eds: E. Ravenm, B. Dunford. The Royal Society of Chemistry, London 2016, 245–271.KudalkarS.N.RouzeraC.A.MarnettL.J.The peroxidase and cyclooxygenase activity of prostaglandin H synthasePeroxdasesHemeRavenmE.DunfordB.The Royal Society of ChemistryLondon201624527110.1039/9781782622628-00245Search in Google Scholar
Strauss K.I.: Antiinflammatory and neuroprotective actions of COX2 inhibitors in the injured brain. Brain Behav. Immun., 2008; 22: 285–298.StraussK.I.Antiinflammatory and neuroprotective actions of COX2 inhibitors in the injured brainBrain Behav. Immun20082228529810.1016/j.bbi.2007.09.011Search in Google Scholar
Breder C., Dewitt D., Kraig R.P.: Characterization of inducible cyclooxygenase in rat brain. J. Comp. Neurol., 1995; 355: 296–315.BrederC.DewittD.KraigR.P.Characterization of inducible cyclooxygenase in rat brainJ. Comp. Neurol199535529631510.1002/cne.903550208Search in Google Scholar
Yamagata K., Andreasson K.I., Kaufmann W.E., Barnes C.A., Worley P.F.: Expression of a mitogen-inducible cyclooxygenase in brain neurons: Regulation by synaptic activity and glucocorticoids. Neuron, 1993; 11: 371–386.YamagataK.AndreassonK.I.KaufmannW.E.BarnesC.A.WorleyP.F.Expression of a mitogen-inducible cyclooxygenase in brain neurons: Regulation by synaptic activity and glucocorticoidsNeuron19931137138610.1016/0896-6273(93)90192-TSearch in Google Scholar
López D.E., Ballaz S.J.: The role of brain cyclooxygenase-2 (Cox-2) beyond neuroinflammation: Neuronal homeostasis in memory and anxiety. Mol. Neurobiol., 2020; 57: 5167–5176.LópezD.E.BallazS.J.The role of brain cyclooxygenase-2 (Cox-2) beyond neuroinflammation: Neuronal homeostasis in memory and anxietyMol. Neurobiol2020575167517610.1007/s12035-020-02087-x32860157Search in Google Scholar
Sang N., Zhang J., Marcheselli V., Bazan N.G., Chen C.: Post-synaptically synthesized prostaglandin E2 (PGE2) modulates hippocampal synaptic transmission via a presynaptic PGE2 EP2 receptor. J. Neurosci., 2005; 25: 9858–9870.SangN.ZhangJ.MarcheselliV.BazanN.G.ChenC.Post-synaptically synthesized prostaglandin E2 (PGE2) modulates hippocampal synaptic transmission via a presynaptic PGE2 EP2 receptorJ. Neurosci2005259858987010.1523/JNEUROSCI.2392-05.2005672555916251433Search in Google Scholar
Rouzer C.A., Marnett L.J.: Cyclooxygenases: Structural and functional insights. J. Lipid Res., 2009; 50: S29–S34.RouzerC.A.MarnettL.J.Cyclooxygenases: Structural and functional insightsJ. Lipid Res200950S29S3410.1194/jlr.R800042-JLR200Search in Google Scholar
Smith W.L., Langenbach R.: Why there are two cyclooxygenase isozymes. J. Clin. Invest., 2001; 107: 1491–1495.SmithW.L.LangenbachR.Why there are two cyclooxygenase isozymesJ. Clin. Invest20011071491149510.1172/JCI13271Search in Google Scholar
Blobaum A.L., Marnett L.J.: Structural and functional basis of cyclooxygenase inhibition. J. Med. Chem., 2007; 50: 1425–1441.BlobaumA.L.MarnettL.J.Structural and functional basis of cyclooxygenase inhibitionJ. Med. Chem2007501425144110.1021/jm0613166Search in Google Scholar
Vecchio A.J., Malkowski M.G.: The structure of NS-398 bound to cyclooxygenase-2. J. Struct. Biol., 2011; 176: 254–258.VecchioA.J.MalkowskiM.G.The structure of NS-398 bound to cyclooxygenase-2J. Struct. Biol201117625425810.1016/j.jsb.2011.07.019Search in Google Scholar
Müller N.: COX-2 inhibitors, aspirin, and other potential anti-inflammatory treatments for psychiatric disorders. Front. Psychiatry, 2019; 10: 375.MüllerN.COX-2 inhibitors, aspirin, and other potential anti-inflammatory treatments for psychiatric disordersFront. Psychiatry20191037510.3389/fpsyt.2019.00375Search in Google Scholar
Dinchuk J.E., Car B.D., Focht R.J., Johnston J.J., Jaffee B.D., Covington M.B., Contel N.R., Eng V.M., Collins R.J., Czerniak P.M., et al.: Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II. Nature, 1995; 378: 406–409.DinchukJ.E.CarB.D.FochtR.J.JohnstonJ.J.JaffeeB.D.CovingtonM.B.ContelN.R.EngV.M.CollinsR.J.CzerniakP.M.et alRenal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase IINature199537840640910.1038/378406a0Search in Google Scholar
Langenbach R., Morham S.G., Tiano H.F., Loftin C.D., Ghanayem B.I., Chulada P.C., Mahler J.F., Lee C.A., Goulding E.H., Kluckman K.D., et al.: Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration. Cell, 1995; 83: 483–492.LangenbachR.MorhamS.G.TianoH.F.LoftinC.D.GhanayemB.I.ChuladaP.C.MahlerJ.F.LeeC.A.GouldingE.H.KluckmanK.D.et alProstaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulcerationCell19958348349210.1016/0092-8674(95)90126-4Search in Google Scholar
Lim H., Paria B.C., Das S.K., Dinchuk J.E., Langenbach R., Trzaskos J.M., Dey S.K.: Multiple female reproductive failures in cyclooxygenase 2-deficient mice. Cell, 1997; 91: 197–208.LimH.PariaB.C.DasS.K.DinchukJ.E.LangenbachR.TrzaskosJ.M.DeyS.K.Multiple female reproductive failures in cyclooxygenase 2-deficient miceCell19979119720810.1016/S0092-8674(00)80402-XSearch in Google Scholar
Morham S.G., Langenbach R., Loftin C.D., Tiano H.F., Vouloumanos N., Jennette J.C., Mahler J.F., Kluckman K.D., Ledford A., Lee C.A., Smithies O.: Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse. Cell, 1995; 83: 473–482.MorhamS.G.LangenbachR.LoftinC.D.TianoH.F.VouloumanosN.JennetteJ.C.MahlerJ.F.KluckmanK.D.LedfordA.LeeC.A.SmithiesO.Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouseCell19958347348210.1016/0092-8674(95)90125-6Search in Google Scholar
Stachowicz K., Bobula B., Tokarski K.: NS398, a cyclooxygenase-2 inhibitor, reverses memory performance disrupted by imipramine in C57Bl/6J mice. Brain Res., 2020; 1734: 146741.StachowiczK.BobulaB.TokarskiK.NS398, a cyclooxygenase-2 inhibitor, reverses memory performance disrupted by imipramine in C57Bl/6J miceBrain Res2020173414674110.1016/j.brainres.2020.146741Search in Google Scholar
Stachowicz K.: Behavioral consequences of the co-administration of MTEP and the COX-2 inhibitor, NS398 in mice. Part 1. Behav. Brain Res., 2019; 370: 111961.StachowiczK.Behavioral consequences of the co-administration of MTEP and the COX-2 inhibitor, NS398 in micePart 1. Behav. Brain Res201937011196110.1016/j.bbr.2019.111961Search in Google Scholar
Harrison F.E., Hosseini A.H., McDonald M.P.: Endogenous anxiety and stress responses in water maze and Barnes maze spatial memory task. Behav. Brain Res., 2009; 198: 247–251.HarrisonF.E.HosseiniA.H.McDonaldM.P.Endogenous anxiety and stress responses in water maze and Barnes maze spatial memory taskBehav. Brain Res200919824725110.1016/j.bbr.2008.10.015Search in Google Scholar
Jerusalinsky D., Fin C., Quillfeld J.A., Ferreiara M.B., Schmitz P.K., Da Silva R.C., Walz R., Bazan N.G., Medina J.H., Izquierdo I.: Effect of antagonists of platelet-activating factor receptors on memory of inhibitory avoidance in rats. Behav. Neural Biol., 1994; 62: 1–3.JerusalinskyD.FinC.QuillfeldJ.A.FerreiaraM.B.SchmitzP.K.Da SilvaR.C.WalzR.BazanN.G.MedinaJ.H.IzquierdoI.Effect of antagonists of platelet-activating factor receptors on memory of inhibitory avoidance in ratsBehav. Neural Biol1994621310.1016/S0163-1047(05)80052-4Search in Google Scholar
Loza A.M., Elias V., Wong C.P., Ho E., Bermudez M., Magnusson K.R.: Effects of ibuprofen on cognition and NMDA receptor subunit expression across aging. Neuroscience, 2017; 344: 276–292.LozaA.M.EliasV.WongC.P.HoE.BermudezM.MagnussonK.R.Effects of ibuprofen on cognition and NMDA receptor subunit expression across agingNeuroscience201734427629210.1016/j.neuroscience.2016.12.041530364728057539Search in Google Scholar
Stark D.T., Bazan N.G.: Synaptic and extrasynaptic NMDA receptors differentially modulate neuronal cyclooxygenase-2 function, lipid peroxidation, and neuroprotection. J. Neurosci., 2011; 31: 13710–13721.StarkD.T.BazanN.G.Synaptic and extrasynaptic NMDA receptors differentially modulate neuronal cyclooxygenase-2 function, lipid peroxidation, and neuroprotectionJ. Neurosci201131137101372110.1523/JNEUROSCI.3544-11.2011319723421957234Search in Google Scholar
Packard M.G., Teather L.A.: Double dissociation of hippocampal and dorsal-striatal memory systems by post-training intracerebral injections of 2-amino-5-phosphonopentanoic acid. Behav. Neuro-sci., 1997; 111: 545–551.PackardM.G.TeatherL.A.Double dissociation of hippocampal and dorsal-striatal memory systems by post-training intracerebral injections of 2-amino-5-phosphonopentanoic acidBehav. Neuro-sci199711154555110.1037/0735-7044.111.3.543Search in Google Scholar
Stachowicz K., Sowa-Kućma M., Pańczyszyn-Trzewik P., Misztak P., Marciniak M., Bobula B., Tokarski K.: Behavioral consequences of co-administration of MTEP and the COX-2 inhibitor NS398 in mice. Part 2. Neurosci. Lett., 2021; 741: 135435.StachowiczK.Sowa-KućmaM.Pańczyszyn-TrzewikP.MisztakP.MarciniakM.BobulaB.TokarskiK.Behavioral consequences of co-administration of MTEP and the COX-2 inhibitor NS398 in micePart 2. Neurosci. Lett202174113543510.1016/j.neulet.2020.13543533171212Search in Google Scholar
Cowley T.R., Fahey B., O’Mara S.M.: COX-2, but not COX-1, activity is necessary for the induction of perforant path long-term potentiation and spatial learning in vivo. Eur. J. Neurosci., 2008; 27: 2999–3008.CowleyT.R.FaheyB.O’MaraS.M.COX-2, but not COX-1, activity is necessary for the induction of perforant path long-term potentiation and spatial learning in vivoEur. J. Neurosci2008272999300810.1111/j.1460-9568.2008.06251.x18540883Search in Google Scholar
Chen C., Magee J.C., Bazan N.G.: Cyclooxygenase-2 regulates prostaglandin E2 signaling in hippocampal long-term synaptic plasticity. J. Neurophysiol., 2002; 87: 2851–2857.ChenC.MageeJ.C.BazanN.G.Cyclooxygenase-2 regulates prostaglandin E2 signaling in hippocampal long-term synaptic plasticityJ. Neurophysiol2002872851285710.1152/jn.2002.87.6.285112037188Search in Google Scholar
Wong C.T., Bestard-Lorigados I., Crawford D.A.: Autism-related behaviors in the cyclooxygenase-2-deficient mouse model. Genes Brain Behav., 2019; 18: e12506.WongC.T.Bestard-LorigadosI.CrawfordD.A.Autism-related behaviors in the cyclooxygenase-2-deficient mouse modelGenes Brain Behav201918e1250610.1111/gbb.1250630027581Search in Google Scholar
Li H.L., Huang B.S., Vishwasrao H., Sutedja N., Chen W., Jin I., Hawkins R.D., Bailey C.H., Kandel E.R.: Dscam mediates trans-synaptic interactions for remodeling of glutamate receptors in Aplysia during de novo and learning-related synapse formation. Neuron, 2009; 61: 527–540.LiH.L.HuangB.S.VishwasraoH.SutedjaN.ChenW.JinI.HawkinsR.D.BaileyC.H.KandelE.R.Dscam mediates trans-synaptic interactions for remodeling of glutamate receptors in Aplysia during de novo and learning-related synapse formationNeuron20096152754010.1016/j.neuron.2009.01.010Search in Google Scholar
Stachowicz K.: The role of DSCAM in the regulation of synaptic plasticity: Possible involvement in neuropsychiatric disorders. Acta Neurobiol. Exp., 2018; 78: 201–219.StachowiczK.The role of DSCAM in the regulation of synaptic plasticity: Possible involvement in neuropsychiatric disordersActa Neurobiol. Exp20187820121910.21307/ane-2018-019Search in Google Scholar
Neuss H., Huang X., Hetfeld B.K., Deva R., Henklein P., Nigam S., Mall J.W., Schwenk W., Dubiel W.: The ubiquitin- and protea-some-dependent degradation of COX-2 is regulated by the COP9 signalosome and differentially influenced by coxibs. J. Mol. Med., 2007; 85: 961–970.NeussH.HuangX.HetfeldB.K.DevaR.HenkleinP.NigamS.MallJ.W.SchwenkW.DubielW.The ubiquitin- and protea-some-dependent degradation of COX-2 is regulated by the COP9 signalosome and differentially influenced by coxibsJ. Mol. Med20078596197010.1007/s00109-007-0197-ySearch in Google Scholar
Head E., Lott I.T., Patterson D., Doran E., Haier R.J.: Possible compensatory events in adult Down syndrome brain prior to the development of Alzheimer disease neuropathology: Targets for nonpharmacological intervention. J. Alzheimers Dis., 2007; 11: 61–76.HeadE.LottI.T.PattersonD.DoranE.HaierR.J.Possible compensatory events in adult Down syndrome brain prior to the development of Alzheimer disease neuropathology: Targets for nonpharmacological interventionJ. Alzheimers Dis200711617610.3233/JAD-2007-11110Search in Google Scholar
Jia Y.L., Jing L.J., Li J.Y., Lu J.J., Han R., Wang S.Y., Peng T., Jia Y.J.: Expression and significance of DSCAM in the cerebral cortex of APP transgenic mice. Neurosci. Lett., 2011; 491: 153–157.JiaY.L.JingL.J.LiJ.Y.LuJ.J.HanR.WangS.Y.PengT.JiaY.J.Expression and significance of DSCAM in the cerebral cortex of APP transgenic miceNeurosci. Lett201149115315710.1016/j.neulet.2011.01.028Search in Google Scholar
Cillero-Pastor B., Caramés B., Lires-Deán M., Vaamonde-García C., Blanco F.J, López-Armada M.J.: Mitochondrial dysfunction activates cyclooxygenase 2 expression in cultured normal human chondrocytes. Arthritis Rheumat., 2008; 58: 2409–2419.Cillero-PastorB.CaramésB.Lires-DeánM.Vaamonde-GarcíaC.BlancoF.JLópez-ArmadaM.J.Mitochondrial dysfunction activates cyclooxygenase 2 expression in cultured normal human chondrocytesArthritis Rheumat2008582409241910.1002/art.23644Search in Google Scholar
Kubis A.M., Janusz M.: Alzheimer disease: New prospects in therapy and applied experimental models. Postępy Hig. Med. Dośw., 2008; 62: 372–392.KubisA.M.JanuszM.Alzheimer disease: New prospects in therapy and applied experimental modelsPostępy Hig. Med. Dośw200862372392Search in Google Scholar
Hoozemans J.J., Rozemuller A.J., Janssen I., De Groot C.J., Veerhuis R., Eikelenboom P.: Cyclooxygenase expression in microglia and neurons in Alzheimer disease and control brain. Acta Neuropathol., 2001; 101: 2–8.HoozemansJ.J.RozemullerA.J.JanssenI.De GrootC.J.VeerhuisR.EikelenboomP.Cyclooxygenase expression in microglia and neurons in Alzheimer disease and control brainActa Neuropathol20011012810.1007/s004010000251Search in Google Scholar
Yermakova A.V., O’Banion M.K.: Downregulation of neuronal cyclooxygenase-2 expression in end stage Alzheimer disease. Neurobiol. Aging, 2001; 22: 823–836.YermakovaA.V.O’BanionM.K.Downregulation of neuronal cyclooxygenase-2 expression in end stage Alzheimer diseaseNeurobiol. Aging20012282383610.1016/S0197-4580(01)00303-7Search in Google Scholar
Medeiros R., Figueiredo C.P., Pandolfo P., Duarte F.S., Prediger R.D., Passos G.F., Calixto J.B.: The role of TNF-α signaling pathway on COX-2 upregulation and cognitive decline induced by β-amyloid peptide. Behav. Brain Res., 2010; 209: 165–173.MedeirosR.FigueiredoC.P.PandolfoP.DuarteF.S.PredigerR.D.PassosG.F.CalixtoJ.B.The role of TNF-α signaling pathway on COX-2 upregulation and cognitive decline induced by β-amyloid peptideBehav. Brain Res201020916517310.1016/j.bbr.2010.01.04020122965Search in Google Scholar
Strauss K.I., Marini A.M.: Cyclooxygenase-2 inhibition protects cultured cerebellar granule neurons from glutamate-mediated cel death. J. Neurotrauma, 2002; 19: 627–638.StraussK.I.MariniA.M.Cyclooxygenase-2 inhibition protects cultured cerebellar granule neurons from glutamate-mediated cel deathJ. Neurotrauma20021962763810.1089/089771502753754091145632212042097Search in Google Scholar
Grishin A.V., Wang J., Potoka D.A., Hackam D.J., Upperman J.S., Boyle P., Zamora R., Ford H.R.: Lipopolysaccharide induces cyclooxygenase-2 in intestinal epithelium via a noncanonical p38 MAPK pathway. J. Immunol., 2006; 176: 580–588.GrishinA.V.WangJ.PotokaD.A.HackamD.J.UppermanJ.S.BoyleP.ZamoraR.FordH.R.Lipopolysaccharide induces cyclooxygenase-2 in intestinal epithelium via a noncanonical p38 MAPK pathwayJ. Immunol200617658058810.4049/jimmunol.176.1.58016365453Search in Google Scholar
Akter K., Lanza E.A., Martin S.A., Myronyuk N., Rua M., Raffa R.B.: Diabetes mellitus and Alzheimer disease: Shared pathology and treatment? Br. J. Clin. Pharmacol., 2011; 71: 365–376.AkterK.LanzaE.A.MartinS.A.MyronyukN.RuaM.RaffaR.B.Diabetes mellitus and Alzheimer disease: Shared pathology and treatment? BrJ. Clin. Pharmacol20117136537610.1111/j.1365-2125.2010.03830.x304554521284695Search in Google Scholar
Tabecka-Lonczyńska A., Mytych J., Solek P., Kulpa-Greszta M., Jasiewicz P., Sowa-Kućma M., Stachowicz K., Koziorowski M.: IGF-1 as selected growth factor multi-response to antidepressant-like substances activity in C57BL/6J mouse testis model. Acta Histochem., 2021; 123: 151685.Tabecka-LonczyńskaA.MytychJ.SolekP.Kulpa-GresztaM.JasiewiczP.Sowa-KućmaM.StachowiczK.KoziorowskiM.IGF-1 as selected growth factor multi-response to antidepressant-like substances activity in C57BL/6J mouse testis modelActa Histochem202112315168510.1016/j.acthis.2021.15168533556704Search in Google Scholar
Schaefer E.J., Bongard V., Beiser A.S., Lamon-Fava S., Robins S.J., Au R., Tucker K.L., Kyle D.J., Wilson P.W., Wolf P.A.: Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: The Framingham Heart Study. Arch. Neurol., 2006; 63: 1545–1550.SchaeferE.J.BongardV.BeiserA.S.Lamon-FavaS.RobinsS.J.AuR.TuckerK.L.KyleD.J.WilsonP.W.WolfP.A.Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: The Framingham Heart StudyArch. Neurol2006631545155010.1001/archneur.63.11.154517101822Search in Google Scholar